Kai Zhao

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Kai Zhao is an author at First Affiliated Hospital of Zhengzhou University specializing in life sciences, nrf2 signaling pathway, and nrf2 pathway activation.

ORCID

Publications per year

2018–2022

Publications

DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-kB signaling pathway.

Kai Zhao, LB Wen · PubMed · 2018 · 29 citations

Medicine, Pharmacology, Toxicology +17

Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram

Jinbo Qi, Ankang Gao, Xiaoyue Ma et al. · Frontiers in Oncology · 2022 · 23 citations · Full text

Medicine, Oncology, Radiology +16

Zhenbao pill attenuates hydrogen peroxide–induced apoptosis by inhibiting autophagy in human umbilical vein endothelial cells

Yuchen Jia, Xiaoxue Chen, Yajing Chen et al. · Journal of Ethnopharmacology · 2021 · 20 citations

Life Sciences, Cell Biology, Pharmacology +13

Vitamin B2 blocks development of Alzheimer’s disease in APP/PS1 transgenic mice via anti-oxidative mechanism

Rong Zhao, Huajun Wang, Kai Zhao · Tropical Journal of Pharmaceutical Research · 2018 · 17 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

1–4 of 4